Literature DB >> 2871151

Correlation between in-vitro microsomal enzyme activity and whole organ hepatic elimination kinetics: analysis with a dispersion model.

M S Roberts, M Rowland.   

Abstract

A new model, the dispersion model of hepatic elimination, is applied to the correlation between in-vitro microsomal data and corresponding rat isolated perfused liver data for a number of drugs reported in the literature, whose extraction ratio varies over the range of 0.01 to 0.995. The dispersion model described the data better than either the 'well-stirred' model or the 'parallel-tube' model, two other widely used models of hepatic elimination. The experimental data support the concept that elimination of solutes is affected by is a considerable dispersion on passage through the liver.

Entities:  

Mesh:

Year:  1986        PMID: 2871151     DOI: 10.1111/j.2042-7158.1986.tb04540.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  22 in total

1.  Modeling of hepatic elimination and organ distribution kinetics with the extended convection-dispersion model.

Authors:  M S Roberts; Y G Anissimov
Journal:  J Pharmacokinet Biopharm       Date:  1999-08

2.  Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes.

Authors:  Kiyomi Ito; J Brian Houston
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.200

3.  Residence time distributions of solutes in the perfused rat liver using a dispersion model of hepatic elimination: 1. Effect of changes in perfusate flow and albumin concentration on sucrose and taurocholate.

Authors:  M S Roberts; S Fraser; A Wagner; L McLeod
Journal:  J Pharmacokinet Biopharm       Date:  1990-06

4.  Availability predictions by hepatic elimination models for Michaelis-Menten kinetics.

Authors:  M S Roberts; J D Donaldson; D Jackett
Journal:  J Pharmacokinet Biopharm       Date:  1989-12

Review 5.  The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance.

Authors:  David G Le Couteur; Robin Fraser; Sarah Hilmer; Laurent P Rivory; Allan J McLean
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 6.  Prediction of hepatic clearance in human from in vitro data for successful drug development.

Authors:  Masato Chiba; Yasuyuki Ishii; Yuichi Sugiyama
Journal:  AAPS J       Date:  2009-04-30       Impact factor: 4.009

Review 7.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

8.  Residence time distributions of solutes in the perfused rat liver using a dispersion model of hepatic elimination: 2. Effect of pharmacological agents, retrograde perfusions, and enzyme inhibition on evans blue, sucrose, water, and taurocholate.

Authors:  M S Roberts; S Fraser; A Wagner; L McLeod
Journal:  J Pharmacokinet Biopharm       Date:  1990-06

Review 9.  Clinical significance of pharmacokinetic models of hepatic elimination.

Authors:  D J Morgan; R A Smallwood
Journal:  Clin Pharmacokinet       Date:  1990-01       Impact factor: 6.447

10.  Correlation of unbound plasma clearances of fifteen extensively metabolized drugs between humans and rats.

Authors:  W L Chiou; F H Hsu
Journal:  Pharm Res       Date:  1988-10       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.